It is suggested that although FGF-19 and FGF-21 are activated under different conditions, they show a similar function in their controlling of glucose and insulin metabolism, energy and weight balance as well as lipid concentrations, particularly in metabolic disorders such as obesity or diabetes [22,23]. This evidence concerns the gene INS and metabolic disease.